Shows / Rx for Biotech
Rx for Biotech
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex…
Episodes
- Rx for Biotech
The IRA 1-year Anniversary Episode: What Lies Ahead?
The Inflation Reduction Act was signed into law in August 2022. In this podcast episode, we look into what lies ahead as the policy implementation begins. Our…
- Rx for Biotech
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD. Ratio…
- Rx for Biotech
ASGCT Policy Summit Preview
Listen to Francesca Cook, VP of Market Access at Regenexbio, as she provides an overview of the program and what to expect at the American Society of Gene and…
- Rx for Biotech
How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes
In this podcast episode, our guest is Mark McDonough, CEO of ChromaCode. ChromaCode is an innovator in genomics with a multiplexing platform that is driving…
- Rx for Biotech
How Medicenna is Developing "Superkines" as Novel Immunotherapies
In this podcast episode, our guest is Dr. Fahar Merchant, President and CEO of Medicenna Therapeutics. Medicenna is a clinical stage immunotherapy company that…
- Rx for Biotech
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing
In this podcast episode, Tomasz George, Chief Scientific Officer at Virax Biolabs, shares how the company's ViraxImmune™ technology platform will empower…
- Rx for Biotech
Novel Immunotherapy approaches to engaging the Innate Immune System
In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer…
- Rx for Biotech
Emerging Therapies for Rare Genetic Mitochondrial Diseases
Reneo Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases including…
- Rx for Biotech
Harnessing the Cell Cycle to Treat Cancer and other Serious Diseases
In this podcast episode, Cyclacel CEO and President, Spiro Rombotis, shares how the company, is exploiting deeper understanding of molecular oncology to…
- Rx for Biotech
American Society of Gene and Cell Therapy Meeting Highlights
Chris Leidli reviews scientific and clinical highlights from the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting with guest, Benjamin…
- Rx for Biotech
Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD
In this podcast episode, Dr. Philip Kantoff, the CEO, CMO, and Co-Founder of Convergent Therapeutics reviews the company's efforts to develop next-generation…
- Rx for Biotech
Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron
FibroBiologics is the leading biotech company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic…
- Rx for Biotech
Erandi De Silva, PhD on Building a Gene Therapy Pipeline and Culture
In this podcast episode, Dr. Erandi De Silva discusses the hybrid approach to gene therapy development at Forge Biologics, Inc., an emerging leader in the…
- Rx for Biotech
Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, PhD
Forge Biologics is on a mission to enable access to life-changing gene therapies and help bring them from idea into reality. In this podcast episode, we learn…
- Rx for Biotech
AACR 2023 Preview
This podcast episode previews the key precision medicine and cellular therapy data being showcased at this year's American Association of Cancer Research…
- Rx for Biotech
New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD
Allen Davidoff, PhD is the Founder and CEO of XORTX Therapeutics, Inc., a drug based biotechnology company primarily focused on orphan disease indications…
- Rx for Biotech
FDA AMAT for Regenerative Medicine Therapies Workshop Recap
This podcast episode provides a short recap of the day long workshop hosted by the FDA’s Office of Therapeutic Products (OTP) a new office within CBER. The…
- Rx for Biotech
Don Davis, PhD, MBA on Challenges in Scaling Life Science Companies
As Life Science companies grow, they become less efficient. In this podcast episode, Dr. Donald Davis explains what scaling challenges are and what companies…
- Rx for Biotech
Applications of AI and Machine Learning in BioPharma and Healthcare
Anyone who has experimented with ChatGPT can get a sense of the potential of generative AI. AI powers driverless cars, spots signs of disease on medical…
- Rx for Biotech
A Look Ahead to 2023 Biopharma M&A, Venture Financing, Licensing and Partnerships
In this podcast episode, we recap highlights from JPM Healthcare conference with Chris Dokomajilar from DealForma, Inc., and review 2023 outlook for Biopharma…
- Rx for Biotech
Biopharma Products and Companies to Watch in 2023
In this podcast episode, Chris provides a short preview of biotechnology and pharmaceutical companies to watch in 2023.
- Rx for Biotech
American Society of Hematology Highlights
This podcast episode covers the highlights from this year’s American Society of Hematology Annual Meeting that took place in New Orleans in early December…
- Rx for Biotech
Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows
OncoOne is a biotech company developing novel therapeutics for patients with solid tumors and autoimmune diseases. In this podcast episode, Brent Meadows…
- Rx for Biotech
How to Improve Customer Engagement in 2023
In this podcast episode, our guest, Karoline Eastman, SVP of Customer Experience and Strategy Lead at Pixacore, discusses new digital trends for pharma in 2023…
- Rx for Biotech
Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah
Our guest in this episode is Cove Therapeutics CEO, Niren Shah, who discusses the pitfalls of current viral vector based gene therapies and shares how Cove's…
- Rx for Biotech
Meeting on the Mesa Roundtable Part 2: Applying "A-Cell" Concepts when Developing Cell Therapies
There are many hurdles to streamlined, cost-effective manufacturing of cell and gene therapy products. To help address this, the Alliance for Regenerative…
- Rx for Biotech
Meeting on the Mesa Roundtable Part 1: 'A-Cell' Principles of Quality by Design
There are many hurdles to streamlined, cost-effective manufacturing of cell and gene therapy products. To help address this, the Alliance for Regenerative…
- Rx for Biotech
IRA Impact on Biopharma Drug Development
The Inflation Reduction Act was signed into law in August 2022 and is one of the most significant pieces of healthcare reform since the Affordable Care Act. In…
- Rx for Biotech
OTAT Townhall Insights for Developers of Gene Therapies
The FDA’s Office of Tissues and Advanced Therapies hosted their first virtual town hall to answer industry questions related to gene therapy chemistry…
- Rx for Biotech
Insights into the Cell and Gene Therapy Landscape
Twice a year, the Alliance for Regenerative Medicine (ARM) surveys the cell and gene therapy landscape to advance the field and provide an update to their…
- Rx for Biotech
Medical Communications after the Pandemic
In this episode, Jan Hannon and Lisa Hefner from BluPrint Oncology dig deeper into scientific and medical communications and how health care provider education…
- Rx for Biotech
Best Practices in Market Access, Trade and Distribution
In this episode, Paul Callahan, President and Founder of CDT Pharma Strategies discusses market access, trade and distribution best practices for novel…
Rx for BiotechChandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems
In this episode, Dr. Ramanathan discusses best practices in Pharmaceutical, Biotechnology, and Academic partnerships, alliance management, and innovation.
- Rx for Biotech
Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris…
Rx for BiotechCRISPR and Gene Editing for Human Disease
Our guest in this episode is Dr. Andrew Garst. We discuss the technology behind powerful new genome editing tools that are driving new therapies to treat…
- Rx for Biotech
The Future of Cell and Gene Therapies
During this episode, we explore the key opportunities and challenges with the future commercialization of innovative personalized therapies with our guest…
- Rx for Biotech
Regulatory Challenges in Biotech
In this episode, Dr. Katie Graham reviews FDA regulatory review process for innovative new biotechnology and pharmaceutical products. Dr. Graham shares best…